Inhibition of sodium‐glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis‐related kidney disease-Reference-Cited by-同舟云学术

Inhibition of sodium‐glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis‐related kidney disease

Published:2019-11 Issue:12 Volume:9 Page:2016-2024
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Nagoya Takuro¹,Kamimura Kenya¹^ORCID,Goto Ryo¹,Shinagawa‐Kobayashi Yoko¹,Niwa Yusuke¹,Kimura Atsushi¹,Sakai Norihiro¹,Ko Masayoshi¹,Nishina Hiroshi²,Terai Shuji¹

Affiliation:

1. Division of Gastroenterology and Hepatology Graduate School of Medical and Dental Sciences Niigata University Japan

2. Department of Developmental and Regenerative Biology Medical Research Institute Tokyo Medical and Dental University Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.12734

Reference42 articles.

1. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Non-alcoholic fatty liver disease

4. Non-alcoholic fatty liver disease and risk of type 2 diabetes

5. Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of Gliflozins in Nonalcoholic Hepatic Steatosis;SCT Proceedings in Interdisciplinary Insights and Innovations;2023-11-10

2. Device implant based on poly (lactic acid) with vitamin E for vaccine delivery system in Tilapia: Study for biocompatibility and biodegradation;Fish and Shellfish Immunology Reports;2022-12

3. Effects of a selective PPARα modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model;Biochemical and Biophysical Research Communications;2022-10

4. Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model;Biochemical and Biophysical Research Communications;2022-03

5. Antioxidant Roles of SGLT2 Inhibitors in the Kidney;Biomolecules;2022-01-16